Targeting EME1 Increases the Sensitivity of Camptothecin in Nasopharyngeal Carcinoma Cells

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Essential meiotic structure-specific endonuclease 1 (EME1) is crucial for genomic stability in cancers.
• The role and expression of EME1 in nasopharyngeal carcinoma (NPC) are not well understood.

Purpose of the Study:

• To investigate the biological role and expression of EME1 in NPC.
• To evaluate the therapeutic potential of targeting EME1 in NPC.

Main Methods:

• Analysis of EME1 expression in NPC tissues and adjacent noncancerous tissues.
• In vitro and in vivo studies involving EME1 knockdown in NPC cells.
• Assessment of NPC cell proliferation, migration, and drug sensitivity (camptothecin, olaparib) after EME1 modulation.

Main Results:

• EME1 was overexpressed in NPC tissues and correlated with poorer survival.
• EME1 knockdown inhibited NPC cell proliferation and migration.
• Silencing EME1 sensitized NPC cells to camptothecin and olaparib, enhancing ATM-CHEK2 phosphorylation and inducing nuclear abnormalities.

Conclusions:

• EME1 is a potential therapeutic target in NPC.
• Combining EME1 modulation with camptothecin or olaparib may represent an effective treatment strategy for NPC.